Probiotic Pre-treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats

Archives of Drug Information
Hani Al-SalamiMomir Mikov

Abstract

AIM: To investigate the influence of probiotic pre-treatment on the permeation of the antidiabetic drug gliclazide in healthy and diabetic rats. METHODS: Wistar rats (age 2-3 months, weight 350 +/- 50 g) were randomly allocated into one of 4 groups (N = 16 each group): healthy control, healthy probiotic, diabetic control, and diabetic probiotic. Probiotics (75 mg/kg, equal quantities of Lactobacillus acidophilus, Bifidobacterium lactis, and Lactobacillus rhamnosus) were administered twice a day for three days to the appropriate groups after diabetes had been induced with alloxan i.v. 30 mg/kg. Rats were sacrificed, ileal tissues mounted in Ussing chambers and gliclazide (200 microg/mL) was administered for the measurement of the mucosal to serosal absorption Jss((MtoS)) and serosal to mucosal secretion Jss((StoM)) of gliclazide. RESULTS: Treatment of healthy rats with probiotics reduced Jss((MtoS)) of gliclazide from 1.2 +/- 0.3 to 0.3 +/- 0.1 microg/min/cm(2) (P < 0.01) and increased Jss((StoM))from 0.6 +/- 0.1 to 1.4 +/- 0.3 (P < 0.01) resulting in net secretion while, in diabetic tissues, treatment with probiotics increased both Jss((MtoS)) and Jss((StoM))fluxes of gliclazide to the comparable levels of healthy tissues resul...Continue Reading

References

Jan 1, 1977·Drugs·J M Hansen, L K Christensen
Jan 1, 1991·Diabetes Research and Clinical Practice·D B CampbellC Nathan
Aug 20, 1990·The American Journal of Medicine·R J Smith
Jan 1, 1995·Annual Review of Physiology·R BansilJ T LaMont
Apr 1, 1996·Environmental Health Perspectives·K BachmannD White
Jan 1, 1996·Journal of Drug Targeting·J Li, I J Hidalgo
Apr 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M BoissetJ I Pachot
May 29, 2000·Journal of Gastroenterology and Hepatology·M IidaM Hori
Aug 30, 2000·Microbes and Infection·J S Gunn
Nov 14, 2000·The American Journal of Pathology·M F FrommD Schrenk
Feb 7, 2001·The American Journal of Clinical Nutrition·A Bezkorovainy
Dec 28, 2002·Diabetes·Alexandra E ButlerPeter C Butler
Jan 30, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Mohammad-Reza RouiniMohammad-Hosein Tahami
Mar 22, 2003·Clinical Pharmacokinetics·Facundo Garcia-BournissenGideon Koren
Aug 27, 2003·Metabolism: Clinical and Experimental·Guntram Schernthaner
Oct 10, 2003·Clinical Pharmacology and Therapeutics·Ji-Young ParkJae-Gook Shin
Nov 25, 2003·Gut·C G DietrichR P J Oude Elferink
Jan 7, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Lauretta M S ChanBarry H Hirst
Apr 28, 2004·Diabetes Care·Zachary T Bloomgarden
Jun 29, 2004·Journal of Clinical Gastroenterology·Eugenia BruzzeseAlfredo Guarino
Sep 9, 2004·Alimentary Pharmacology & Therapeutics·P MarteauP Seksik
Sep 9, 2004·Alimentary Pharmacology & Therapeutics·W Kruis
Nov 9, 2004·International Journal of Clinical Practice·G BelcherM Valbuena
Dec 27, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Martin Werle, Martin Hoffer
May 5, 2006·Bulletin of Experimental Biology and Medicine·V K Khavinson
Nov 11, 2006·BMJ : British Medical Journal·Cathy HammermanMichael Kaplan
Jan 4, 2007·The Journal of Clinical Investigation·Daniel J Drucker
Jun 19, 2008·Methods and Findings in Experimental and Clinical Pharmacology·H Al-SalamiM Mikov

❮ Previous
Next ❯

Citations

Oct 12, 2012·Applied Biochemistry and Biotechnology·Nebojša PavlovićMomir Mikov
Jan 21, 2016·Food & Function·Ram Mohan ThusharaMohammed H Moghadasian
Jan 23, 2016·European Journal of Drug Metabolism and Pharmacokinetics·Zuzana MatuskovaEva Anzenbacherova
Nov 26, 2015·Journal of Pharmacological and Toxicological Methods·Miroslav RadenkovićMilica Prostran
May 15, 2013·Journal of Diabetes Research·Mladena Lalić-PopovićMomir Mikov
Dec 12, 2012·Diabetes/metabolism Research and Reviews·Harsh PanwarSunita Grover
Oct 19, 2017·European Journal of Drug Metabolism and Pharmacokinetics·Momir MikovHani Al-Salami
Jul 1, 2020·Expert Opinion on Drug Delivery·Susbin Raj WagleHani Al-Salami
Apr 2, 2019·Frontiers in Nutrition·Veronica LazarMariana Carmen Chifiriuc
Jul 28, 2020·Foods·Irena ŽuntarPredrag Putnik
Nov 20, 2020·Food & Function·Amalia E YanniVaios T Karathanos
Dec 11, 2020·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Maja ĐanićMomir Mikov

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Epigenetics Insights from Twin Studies

Find the latest research on epigenetics and twin studies here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

Related Papers

International Journal of Pharmaceutics
Hakon H SigurdssonClaus-Michael Lehr
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
Hee Ji LeeJ Paul Fawcett
© 2021 Meta ULC. All rights reserved